These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3784768)

  • 1. Opiate actions on mesocortical dopamine metabolism in the rat.
    Kim HS; Iyengar S; Wood PL
    Life Sci; 1986 Nov; 39(21):2033-6. PubMed ID: 3784768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: tentative mu-2 opioid control of mesocortical dopaminergic projections.
    Kim HS; Iyengar S; Wood PL
    Life Sci; 1987 Oct; 41(14):1711-5. PubMed ID: 2821337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine stimulation of mesolimbic and mesocortical but not nigrostriatal dopamine release in the rat as reflected by changes in 3-methoxytyramine levels.
    Wood PL; Rao TS
    Neuropharmacology; 1991 Apr; 30(4):399-401. PubMed ID: 1852270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist action of the agonist/antagonist analgesic butorphanol on dopamine metabolism in the nucleus accumbens of the rat.
    Iyengar S; Kim HS; Wood PL
    Neurosci Lett; 1987 Jun; 77(2):226-30. PubMed ID: 3601233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endogenous kappa agonist, dynorphin(1-13), does not alter basal or morphine-stimulated dopamine metabolism in the nigrostriatal pathway of the rat.
    Wood PL; Kim HS; Cosi C; Iyengar S
    Neuropharmacology; 1987 Nov; 26(11):1585-8. PubMed ID: 2893309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
    Deutch AY; Tam SY; Freeman AS; Bowers MB; Roth RH
    Eur J Pharmacol; 1987 Feb; 134(3):257-64. PubMed ID: 3569414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA; Boyar WC; Oei E; Wood PL
    Brain Res; 1988 Sep; 460(1):76-82. PubMed ID: 3219572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
    Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T
    J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine and nigrostriatal function in the rat and mouse: the role of nigral and striatal opiate receptors.
    Wood PL; Richard JW
    Neuropharmacology; 1982 Dec; 21(12):1305-10. PubMed ID: 6296716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of mesolimbic dopaminergic projections by beta-endorphin in the rat.
    Iyengar S; Kim HS; Marien MR; McHugh D; Wood PL
    Neuropharmacology; 1989 Feb; 28(2):123-8. PubMed ID: 2524013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus.
    Spampinato U; Esposito E; Romandini S; Samanin R
    Brain Res; 1985 Feb; 328(1):89-95. PubMed ID: 2578858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phencyclidine in combination with morphine on the levels of met-enkephalin, dopamine, DOPAC and HVA in discrete brain areas of mice.
    Nabeshima T; Hiramatsu M; Furukawa H; Kameyama T
    Neuropharmacology; 1985 Aug; 24(8):805-9. PubMed ID: 3837860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate and "day-after" effects of morphine on dopamine and serotonin metabolism in various structures of the rat brain.
    Antkiewicz-Michaluk L; Romańska I; Vetulani J
    Pol J Pharmacol; 1995; 47(4):355-8. PubMed ID: 8616517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex.
    Izenwasser S; Werling LL; Cox BM
    Brain Res; 1990 Jun; 520(1-2):303-9. PubMed ID: 2145054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences.
    Wood PL
    Peptides; 1983; 4(5):595-601. PubMed ID: 6318197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of various centrally acting drugs on the efflux of dopamine metabolites from the rat brain.
    Westerink BH; Kikkert RJ
    J Neurochem; 1986 Apr; 46(4):1145-52. PubMed ID: 3950621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of spontaneous ingestion of ethanol on brain dopamine metabolism.
    Fadda F; Mosca E; Colombo G; Gessa GL
    Life Sci; 1989; 44(4):281-7. PubMed ID: 2915601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic sensitivity to effect of ethanol on dopaminergic system in alcohol preferring rats.
    Fadda F; Colombo G; Gessa GL
    Alcohol Alcohol Suppl; 1991; 1():439-42. PubMed ID: 1845574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.